Exelixis (EXEL) Tax Provisions (2010 - 2026)
Exelixis (EXEL) recorded quarterly Tax Provisions of $57.2 million in Q2 2026, up 601.23% quarter-over-quarter from $8.2 million in Q1 2026, and up 24.19% on a YoY basis from $46.1 million in Q2 2025.
Exelixis (EXEL) Tax Provisions (2010 - 2026) Analysis & Trends
Exelixis' Tax Provisions history runs 14 years deep, the most recent figure standing at $57.2 million for Q2 2026.
- In Q2 2026, Tax Provisions rose 24.19% year-over-year to $57.2 million; the TTM figure through Apr 2026 stood at $169.8 million (down 12.71% YoY), while the FY2026 annual figure was $158.6 million, down 1.08% from the prior year.
- Tax Provisions was $57.2 million for Q2 2026 at Exelixis, up from $8.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $66.7 million in Q2 2024 to a low of -$1.3 million in Q4 2022.
- Historically, Tax Provisions has averaged $28.1 million across 5 years, with a median of $18.8 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions tumbled 105.49% in 2022, then soared 1497.21% in 2023.
- A 5-year view of Tax Provisions shows it stood at -$1.3 million in 2022, then jumped by 1497.21% to $17.5 million in 2023, then soared by 109.93% to $36.8 million in 2024, then soared by 59.96% to $58.8 million in 2025, then declined by 2.74% to $57.2 million in 2026.
- The last three Tax Provisions figures came in at $57.2 million (Q2 2026), $8.2 million (Q1 2026), and $58.8 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 57.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 57.22 Mn |
| Jan 2, 2026 | 8.16 Mn |
| Oct 3, 2025 | 58.84 Mn |
| Jul 4, 2025 | 45.57 Mn |
| Apr 4, 2025 | 46.07 Mn |
| Jan 3, 2025 | 44.91 Mn |
| Sep 27, 2024 | 36.78 Mn |
| Jun 28, 2024 | 66.73 Mn |
| Mar 29, 2024 | 11.95 Mn |
| Dec 29, 2023 | 17.52 Mn |
| Sep 29, 2023 | 4.78 Mn |
| Jun 30, 2023 | 19.21 Mn |
| Mar 31, 2023 | 8.25 Mn |
| Dec 30, 2022 | -1.25 Mn |
| Sep 30, 2022 | 18.83 Mn |
| Jul 1, 2022 | 17.84 Mn |
| Apr 1, 2022 | 16.66 Mn |
| Dec 31, 2021 | 22.86 Mn |
| Oct 1, 2021 | 15.06 Mn |
| Jul 2, 2021 | 28.80 Mn |